Skip to content
Login
Search:
CROI Conference
CROI ConferenceCROI Conference
  • About CROI
    • CROI 2027 Important Dates
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • CROI Abstract Categories
    • Abstract Guidelines and Submission
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Who Can Attend
    • Letter Of Invitation (For Visa And Other Purposes)
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
  • Program
    • CROI 2027 Program
    • Our Voices
    • Media
    • Embargo Policies And Press Release Policies
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • About CROI
    • CROI 2026 Preliminary Important Dates and Deadlines
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • Abstract Guidelines and Submission
    • CROI Abstract Categories
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Oral Abstract Presentation Guidelines
    • Poster Presentation Guidelines
    • Themed Discussion Guidelines
    • Plain Language Summaries: A Mile-High View at CROI 2026
    • People-First Language and the Use of Appropriate Terminology
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Registration
    • Who Can Attend
    • Media Accreditation and Registration
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
    • Scholarship Travel
  • Program
    • CROI 2027 Program
    • CROI 2026 Resources
    • Our Voices
    • Media
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • CROI 2027 Important Dates

Search Results for: node/PEP: Remember Me?

National Survey on the Use of Antibiotics as Sexually Transmitted Infection Prophylaxis in the US

By Jimmy He PharmD, DScMarch 6, 2024

…sexual networking apps used mainly by gay and bisexual men (GBM). Survey domains included sociodemographics, use of antibiotics as STI prophylaxis (including but not limited to doxyPEP), HIV/STI diagnosis history,…

SAFETY AND TOLERABILITY OF ONCE-DAILY BIC/FTC/TAF FOR POSTEXPOSURE PROPHYLAXIS

By Jimmy He PharmD, DScApril 27, 2020

…men. Other participants included 3 heterosexual cisgender men, 1 transgender woman and 2 cisgender women. Most (76.9%) completed college +/- advanced degrees. Behaviors that led to PEP initiation included: receptive…

STRAIN-DEPENDENT EFFECTS OF SIGNAL PEPTIDES ON HIV-1 Env GLYCOSYLATION AND FUNCTIONS

By Jimmy He PharmD, DScApril 22, 2021

HIV-1 Env glycoprotein is a trimer of heterodimeric gp120 and gp41 subunits that are produced from a gp160 precursor. The N terminus of gp160 contains a signal peptide (SP) which…

RANDOMIZED TRIAL OF COMMUNITY HEALTH WORKER DELIVERED DYNAMIC CHOICE HIV PREVENTION

By Jimmy He PharmD, DScMarch 24, 2023

…move between PrEP and PEP and delivered by community health workers (CHW), would increase HIV biomedical prevention coverage among persons at risk in rural Sub-Saharan Africa. Methods: We conducted a…

Variation in EraP Influencees Risk for HLA-B*57:01 Positive Abacavir Hypersensitivity

By Enthusiast Inc MDFebruary 16, 2016

Abacavir (ABC) binds non-covalently to the floor of the peptide-binding groove of HLA-B*57:01, altering the chemistry and shape of the antigen binding cleft.  This allows previously untolerized self-peptides to be…

Characterization of functional profile of HIV-specific CD4+ T cells in VISCONTI group of patients

By Enthusiast Inc MDSeptember 29, 2014

…a median 89 [IQR:73-103] months long interruption of a median 3 [IQR:1.7-5.9] years long HAART initiated within 10 weeks post-infection. Multiparametric flow cytometry assessed HIV-specific CD4 T cells producing IFNγ,…

IMPROVING CLASSIFICATION FOR RECENT HIV INFECTION USING TOP SCORING PAIRS

By Jimmy He PharmD, DScApril 27, 2020

…days; see figure). In contrast, the mean window period of the LAg-Avidity protocol is 106 days (95% CI: 76-146 days). We identified four 4 peptide pairs that outperformed the standard…

276 – Robust HIV-Specific CD4+ and CD8+ T-Cell Responses in Chronic Progressors on Long-Term ART

By Jimmy He PharmD, DScMarch 31, 2026

…Gag-specific T cells as well as the Gag-specific T cell receptor (TCR) repertoire in CPs on long-term ART and HICs. Methods We performed 10-day expansion assays using PBMCs from 5…

Targeting HIV-Infected Cells for Immunotherapy Through HLA-E

By Jimmy He PharmD, DScMarch 6, 2024

…cells can be targeted for CTL-mediated lysis using novel scDbs specific for HLA-E-bound epitopes. Methods: To validate HLA-E as a suitable scDb target, we used the previously characterized [i]M. tuberculosis[/i]-derived…

UNRAVELING ONGOING INFLAMMATION AFTER EARLY ART BY IN-DEPTH ANALYSIS OF LYMPH NODES

By Jimmy He PharmD, DScMarch 3, 2023

…early ART. In-depth analysis of lymph nodes during and after acute HIV-infection, may provide insight into the drivers of this inflammation. Methods: Samples were selected from a multi-centric Belgian cohort…

←1
234567891011121314151617
…1819202122…
232425262728293031323334353637383940414243444546474849505152535455565758596061626364656667686970717273747576777879808182
83→
Copyright © 2026 CROI Foundation/IAS-USA. All Rights Reserved.
Website by Enthusiast, Inc.
  • About CROI
  • Presenters
  • Abstracts
  • Scholarships
  • Program
Footer Menu
Go to Top